The invention relates to new heteroaryl derivatives of the formula wherein X 1 is selected from the group consisting of : N and CH; X 2 is selected from the group consisting of : N and CF; (whith the proviso that at least one of X1 and X2 is N), and A is as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.